Phthalate-Induced Dysregulation of Prostaglandin and Angiogenic Function During Ovulation in Women
邻苯二甲酸盐引起的女性排卵期间前列腺素和血管生成功能失调
基本信息
- 批准号:10358879
- 负责人:
- 金额:$ 42.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-01 至 2026-10-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAgonistAngiogenic FactorAnimal ModelAwardBiological AssayBlood capillariesCell ProliferationCell modelCellsChemicalsCouplesCyclic AMPCyclooxygenase InhibitorsDataDefectDoseEndocrine DisruptorsEndothelial CellsEnsureEnvironmental HealthEnvironmental ImpactExhibitsExposure toFGF2 geneFailureFemale infertilityFertilityFertility RatesFoundationsFunctional disorderGoalsHealthcareHousingHumanImpairmentIn VitroInfertilityLinkLiteratureMediator of activation proteinMedicalMental HealthMetabolismModelingMusNatureNon-Steroidal Anti-Inflammatory AgentsOocytesOutcomeOvarianOvarian FollicleOvarian Granulosa CellOvaryOvulationOvulation InhibitionPTGS2 geneParentsPathway interactionsPregnant WomenPrevalenceProcessProductionProstaglandin ProductionProstaglandin-Endoperoxide SynthaseProstaglandinsPublic HealthQuality of lifeReproductive HealthResearchRodent ModelSamplingSignal TransductionSignaling MoleculeSocial FunctioningSocietiesStressSupplementationTestingTimeToxic effectVEGFA geneWomanWomen&aposs HealthWorkangiogenesiscostcritical periodexposed human populationgranulosa cellhuman modelin vivomigrationmouse modelnovelpersonal care productsphthalatesphysical conditioningpreventreceptorreproductivetranslational approachurinary
项目摘要
PROJECT SUMMARY/ABSTRACT
This ONES award will elucidate the mechanisms by which phthalates, a class of endocrine-disrupting chemicals,
disrupt prostaglandin and angiogenic function during the critical period of ovulation. Further, rescue approaches
will be investigated to alleviate phthalate-induced inhibition of ovulation and fertility, which is crucial for
environmental and reproductive health as exposure to phthalates is unavoidable. Phthalates are incorporated in
several common consumer, medical, housing, and personal care products leading to daily human exposure.
However, little is known about the effects of environmentally relevant levels and mixtures of phthalates on
ovulation, especially in women. This is alarming because defects in ovulation are the leading cause of female
infertility. The abundant increase of prostaglandins in the ovary and the surge of new vasculature formation, via
angiogenesis, are vital for ovulation and fertility. Preliminary data for this proposal are the first to show that an
environmentally relevant phthalate mixture decreases the levels of prostaglandins and factors that drive
angiogenesis in human and mouse ovarian samples. Further, the phthalate mixture decreased ovulation rates
by 96% in mouse samples. These findings suggest that environmentally relevant phthalate exposure targets
ovulatory prostaglandin and angiogenic action, which may cause infertility. Our compelling preliminary data also
suggest that supplementation with cyclic adenosine monophosphate, a common cell signaling molecule, to
human ovarian cells may rescue the phthalate-induced decreases in ovulatory prostaglandin and angiogenic
factor levels. A major strength of this proposal is our ability to mimic human exposure to phthalates by the use
of environmentally relevant phthalate mixtures and human ovarian models. These models, as well as in vivo and
in vitro mouse models, will be used to test the hypothesis that phthalates inhibit ovulatory prostaglandin
production and function, leading to impaired angiogenesis and ovulatory failure/infertility. Specific Aim 1 will
elucidate the mechanism by which phthalates decrease ovulatory prostaglandin levels. Specific Aim 2 will
determine the deficiencies in angiogenesis, ovulation, and fertility caused by phthalates. Specific Aim 3 will define
approaches to alleviate phthalate toxicity. These findings will advance environmental health sciences by
providing mechanistic data establishing the impact of environmentally relevant phthalate mixture exposure on
prostaglandin and angiogenic function, which are essential mediators for fertility. Thus, these findings will reveal
novel actions of phthalates on infertility and reproductive dysfunction. Additionally, the use of human samples
and the establishment of rescue approaches provide a translational approach to understanding and mitigating
phthalate toxicities. Infertility in women seeking to conceive leads to a decreased quality of life, including
increased levels of stress, diminished social functioning, and mental and physical health issues. By delineating
the detrimental impacts of phthalate exposure on ovulation and fertility, the overarching goal of this proposal is
to provide a foundation to benefit women’s reproductive and general healthcare.
项目总结/摘要
这个ONES奖将阐明邻苯二甲酸酯,一类内分泌干扰化学品,
在排卵的关键时期破坏前列腺素和血管生成功能。此外,救援方法
将研究减轻邻苯二甲酸酯诱导的排卵和生育抑制,这对
环境和生殖健康,因为接触邻苯二甲酸盐是不可避免的。邻苯二甲酸酯被纳入
几种常见的消费、医疗、住房和个人护理产品,导致人类每天接触。
然而,很少有人知道邻苯二甲酸酯的环境相关水平和混合物的影响,
排卵,尤其是女性。这是令人担忧的,因为排卵缺陷是女性不孕的主要原因。
不孕卵巢中大量增加的甘草素和新血管形成的激增,通过
血管生成,对排卵和生育至关重要。这项提议的初步数据首次表明,
环境相关的邻苯二甲酸酯混合物降低了三尖杉酯素的水平,
人和小鼠卵巢样品中的血管生成。此外,邻苯二甲酸酯混合物降低排卵率
96%的小鼠样本。这些发现表明,与环境相关的邻苯二甲酸酯暴露目标
排卵前列腺素和血管生成作用,可能导致不孕。我们令人信服的初步数据还
提示补充一种常见细胞信号分子环磷酸腺苷,
人卵巢细胞可以挽救邻苯二甲酸酯诱导的排卵前列腺素和血管生成减少,
因素水平。该提案的一个主要优势是我们能够通过使用
环境相关的邻苯二甲酸酯混合物和人类卵巢模型。这些模型,以及体内和
体外小鼠模型将用于检验邻苯二甲酸酯抑制排卵前列腺素的假设
产生和功能,导致血管生成受损和排卵失败/不育。具体目标1将
阐明邻苯二甲酸酯降低排卵前列腺素水平的机制。具体目标2将
确定邻苯二甲酸酯引起的血管生成、排卵和生育能力的缺陷。具体目标3将定义
减轻邻苯二甲酸酯毒性的方法。这些发现将推动环境健康科学,
提供确定环境相关邻苯二甲酸酯混合物暴露对
前列腺素和血管生成功能,这是生育的基本介质。这些发现将揭示
邻苯二甲酸酯对不孕和生殖功能障碍的新作用。此外,使用人体样本
和建立救援方法提供了一个翻译的方法来理解和减轻
邻苯二甲酸酯毒性寻求怀孕的女性不孕症导致生活质量下降,包括
压力增加,社会功能下降,以及心理和身体健康问题。通过划定
邻苯二甲酸酯暴露对排卵和生育能力的不利影响,本提案的总体目标是
为妇女的生殖保健和一般保健奠定基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patrick Ryan Hannon其他文献
Patrick Ryan Hannon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patrick Ryan Hannon', 18)}}的其他基金
Phthalate-Induced Dysregulation of Prostaglandin and Angiogenic Function During Ovulation in Women
邻苯二甲酸盐引起的女性排卵期间前列腺素和血管生成功能失调
- 批准号:
10544036 - 财政年份:2022
- 资助金额:
$ 42.73万 - 项目类别:
Phthalate-Induced Ovulatory Dysfunction in Women
邻苯二甲酸盐引起的女性排卵功能障碍
- 批准号:
10006568 - 财政年份:2019
- 资助金额:
$ 42.73万 - 项目类别:
Phthalate-Induced Ovulatory Dysfunction in Women
邻苯二甲酸盐引起的女性排卵功能障碍
- 批准号:
10241441 - 财政年份:2019
- 资助金额:
$ 42.73万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 42.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 42.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 42.73万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 42.73万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 42.73万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 42.73万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 42.73万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 42.73万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 42.73万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 42.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)